Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

TP Lodise Jr, B Lomaestro… - Clinical Infectious …, 2007 - academic.oup.com
Background. Piperacillin-tazobactam is frequently used to treat Pseudomonas aeruginosa
infections in critically ill patients. In an effort to improve clinical outcomes, an extended …

Prolonged infusions of β‐lactam antibiotics: Implication for antimicrobial stewardship

JM George, TG Towne… - … : The Journal of Human …, 2012 - Wiley Online Library
The optimal dosage and administration of antibiotics are not only important measures to
combat antimicrobial resistance, but they are also integral to antimicrobial stewardship. In …

How to Manage Pseudomonas aeruginosa Infections

M Papadimitriou-Olivgeris, D Jacot, B Guery - … : Biology, Pathogenesis and …, 2022 - Springer
Pseudomonas aeruginosa is a pathogen frequently encountered in healthcare-associated
infections and immunocompromised patients. In bacteremia, this pathogen is associated …

International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British …

LT Hong, KJ Downes, A FakhriRavari… - … : The Journal of …, 2023 - Wiley Online Library
Intravenous β‐lactam antibiotics remain a cornerstone in the management of bacterial
infections due to their broad spectrum of activity and excellent tolerability. β‐lactams are well …

[HTML][HTML] Evidence-based treatment of Pseudomonas aeruginosa infections: a critical reappraisal

A Karruli, C Catalini, C D'Amore, F Foglia, F Mari… - Antibiotics, 2023 - mdpi.com
Multidrug-resistant (MDR)/extensively drug-resistant (XDR) Pseudomonas aeruginosa is
emerging as a major threat related to adverse patient outcomes. The goal of this review is to …

Prolonged versus intermittent infusion of β-lactam antibiotics: a systematic review and meta-regression of bacterial killing in preclinical infection models

S Dhaese, A Heffernan, D Liu, MH Abdul-Aziz… - Clinical …, 2020 - Springer
Background Administering β-lactam antibiotics via prolonged infusions for critically ill
patients is mainly based on preclinical evidence. Preclinical data on this topic have not been …

Should prolonged infusion of ß-lactams become standard of practice?

R Haj-Darrah, EL Pro, RZ Con - Canadian Journal of Hospital …, 2017 - cjhp-online.ca
Clinicians have long debated whether prolonged IV infusion of antimicrobials, including ß-
lactams, is a more effective administration strategy than intermittent (“standard”) infusion. 1 …

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

AJ Kunz Coyne, A El Ghali, D Holger, N Rebold… - Infectious diseases and …, 2022 - Springer
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa
isolates are frequent causes of serious nosocomial infections that may compromise the …

Evaluating biapenem dosage regimens in intensive care unit patients with Pseudomonas aeruginosa infections: a pharmacokinetic/pharmacodynamic analysis using …

Y Hang, Y Chen, L Xue, S Sun, L Liu, J Gao… - International Journal of …, 2018 - Elsevier
This study was conducted to identify optimal dosage regimens and estimate
pharmacokinetic/pharmacodynamic (PK/PD) characteristics of short-infusion (SI) versus …

Clinical efficacy and safety of prolonged versus intermittent administration of antipseudomonal beta-lactam antibiotics in adults with severe acute infections: A meta …

P Kıran, Y Nadir, S Gencer - Journal of Infection and Chemotherapy, 2023 - Elsevier
Introduction In order to compare the clinical efficacy and safety of prolonged versus
intermittent antipseudomonal beta-lactam antibiotic infusion for the treatment of severe acute …